⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

Lupin Pharmaceuticals Inc.: Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupi

DrugsSource: FDA (drug) · Date: 2026-05-27

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Get alerts for Lupin Pharmaceuticals

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
Lupin Pharmaceuticals Inc.
Product
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.
Reason / hazard
Presence of particulate matter: a white thread-like structure in the cartridge
Classification
Class II
Status
Ongoing
Distribution / sold at
Nationwide within U.S
Recall initiated
2026-04-24
Code info
Lots: a) WB00097, WB00094, WB00088, Expires: Jul. 2027; WB00103, Expires: Oct. 2027; WC00016, Expires: Dec. 2027; b) WB00098, WB00092, WB00093, Expires: Jul. 2027; WB00104, WB00106, WB00105, Expires: Oct. 2027.
Product quantity
217,621 pen injectors
Voluntary mandated
Voluntary: Firm initiated
City
Naples
State
FL
Country
United States
Event id
98809
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.